Vascular Malformations_Somatic
Gene: MTOR
Comment on list classification: Vascular malformations are not a prominent feature of the condition caused by germline variants in this gene. Somatic activating mutations are possibly associated with vascular malformations.Created: 21 Jan 2020, 12:34 a.m. | Last Modified: 1 Jul 2020, 11:33 p.m.
Panel Version: 0.9
Comment on mode of pathogenicity: Gain-of-function is the mechanism of diseaseCreated: 21 Jan 2020, 12:32 a.m. | Last Modified: 21 Jan 2020, 12:32 a.m.
Panel Version: 0.28
Haemangiomas are not a prominent feature of Smith-Kingsmore syndrome, which is caused by germline variants in MTOR (PMID: 28892148). A somatic MTOR (p.F1888L) variant was detected in a subject with macrodactyly and bilateral venous malformation of the lower extremities (PMID: 29174369). mTOR inhibitors are important in the management of vascular anomalies. It appears activating mutations in genes in the mTOR pathway are causative of vascular malformations rather than activating mutations in MTOR itself.
Sources: Expert listCreated: 21 Jan 2020, 12:31 a.m.
Mode of inheritance
Other
Phenotypes
Smith-Kingsmore syndrome 616638; Focal cortical dysplasia, type II, somatic 607341
Publications
Gene: mtor has been classified as Amber List (Moderate Evidence).
Gene: mtor has been classified as Amber List (Moderate Evidence).
gene: MTOR was added gene: MTOR was added to Vascular Malformations_Somatic. Sources: Expert list,Expert Review Green Mode of inheritance for gene: MTOR was set to Other Publications for gene: MTOR were set to 29174369; 28892148 Phenotypes for gene: MTOR were set to Smith-Kingsmore syndrome 616638; Focal cortical dysplasia, type II, somatic 607341 Mode of pathogenicity for gene: MTOR was set to Loss-of-function variants (as defined in pop up message) DO NOT cause this phenotype - please provide details in the comments